Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NYSE:AMCR NYSE:CVX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$216.02+0.7%$208.72$181.71▼$244.81$378.98B0.326.29 million shs5.41 million shsAMCRAmcor$38.43-0.2%$39.67$36.25▼$50.94$17.80B0.634.51 million shs2.88 million shsCVXChevron$191.51+0.3%$193.55$134.06▼$214.71$380.42B0.5110.18 million shs7.21 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.10%+1.85%+4.83%-4.48%+18.22%AMCRAmcor+1.11%-0.08%-6.27%-23.60%-16.04%CVXChevron-0.09%+2.58%+2.74%+4.10%+41.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$216.02+0.7%$208.72$181.71▼$244.81$378.98B0.326.29 million shs5.41 million shsAMCRAmcor$38.43-0.2%$39.67$36.25▼$50.94$17.80B0.634.51 million shs2.88 million shsCVXChevron$191.51+0.3%$193.55$134.06▼$214.71$380.42B0.5110.18 million shs7.21 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.10%+1.85%+4.83%-4.48%+18.22%AMCRAmcor+1.11%-0.08%-6.27%-23.60%-16.04%CVXChevron-0.09%+2.58%+2.74%+4.10%+41.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.88Moderate Buy$253.4317.32% UpsideAMCRAmcor 2.77Moderate Buy$49.3328.39% UpsideCVXChevron 2.76Moderate Buy$204.226.63% UpsideCurrent Analyst Ratings BreakdownLatest AMCR, CVX, and ABBV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026CVXChevron Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$212.00 ➝ $214.005/20/2026AMCRAmcor Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetEqual Weight$43.00 ➝ $41.005/15/2026ABBVAbbVie EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$235.005/14/2026ABBVAbbVie Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$294.00 ➝ $298.005/11/2026AMCRAmcor Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)5/11/2026CVXChevron Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$216.00 ➝ $204.005/8/2026AMCRAmcor CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$54.00 ➝ $47.005/8/2026CVXChevron TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$204.00 ➝ $205.005/7/2026AMCRAmcor JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$50.00 ➝ $44.005/7/2026AMCRAmcor Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$50.00 ➝ $51.005/6/2026CVXChevron The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$216.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B6.24$15.26 per share14.16($3.74) per share-57.76AMCRAmcor$15.01B1.18$4.10 per share9.37$25.22 per share1.52CVXChevron$189.03B2.02$16.76 per share11.43$95.08 per share2.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.0321.0513.250.745.79%-576.45%13.39%7/30/2026 (Estimated)AMCRAmcor$511M$1.4310.219.021.163.06%14.55%4.57%N/ACVXChevron$12.30B$5.7729.1614.630.645.79%6.90%4.06%8/7/2026 (Estimated)Latest AMCR, CVX, and ABBV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q3 2026AMCRAmcor$0.96$0.96N/A$0.60$5.71 billion$5.91 billion5/1/2026Q1 2026CVXChevron$1.00$1.41+$0.41$1.11$51.86 billion$47.56 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.923.20%+6.80%340.89%53 YearsAMCRAmcor$2.606.77%+1.74%181.82%5 YearsCVXChevron$7.123.72%+5.80%123.40%38 YearsLatest AMCR, CVX, and ABBV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026AMCRAmcorquarterly$0.656.46%5/28/20265/28/20266/17/20264/29/2026CVXChevronquarterly$1.783.61%5/19/20265/19/20266/10/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68AMCRAmcor1.301.440.95CVXChevron0.211.090.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%AMCRAmcor45.14%CVXChevron72.42%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%AMCRAmcor0.32%CVXChevron0.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableAMCRAmcor77,000462.35 million460.87 millionOptionableCVXChevron43,0391.99 billion1.98 billionOptionableAMCR, CVX, and ABBV HeadlinesRecent News About These CompaniesInsider Selling: Chevron (NYSE:CVX) Director Sells 380,000 Shares of Stock3 hours ago | marketbeat.comNewsom blames Chevron for California's gas-price problem4 hours ago | latimes.comMore Gas Per Barrel of Oil: A Growth Lever for Permian OperatorsMay 22 at 1:42 PM | zacks.comGavin Newsom takes rare step of telling Californians to avoid Chevron: ‘Big Oil is already making billions off Trump’s Iran War’May 22 at 11:31 AM | fortune.comChevron Corporation (CVX) Gained Amid Rise in Commodity PricesMay 22 at 10:30 AM | insidermonkey.comChevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For FridayMay 22 at 9:51 AM | benzinga.comChevron (NYSE:CVX) Stock Price Expected to Rise, Morgan Stanley Analyst SaysMay 22 at 9:41 AM | marketbeat.comKeudell Morrison Wealth Management Invests $2.70 Million in Chevron Corporation $CVXMay 22 at 7:13 AM | marketbeat.comDiamond Hill Capital Management Inc. Acquires 137,505 Shares of Chevron Corporation $CVXMay 22 at 4:40 AM | marketbeat.comAxxcess Wealth Management LLC Purchases 167,118 Shares of Chevron Corporation $CVXMay 22 at 3:21 AM | marketbeat.comGavin Newsom Warns Californians To 'Avoid Chevron,' Says Big Oil Is 'Making Billions Off Trump's Iran War'May 22 at 1:11 AM | benzinga.comShell Divests Uruguay Offshore Interests to QatarEnergy PartnerMay 21 at 1:21 PM | zacks.comAdvisory: Chevron to Participate in Fireside Q&A at Bernstein 42nd Annual Strategic Decisions ConferenceMay 21 at 12:44 PM | finance.yahoo.comSemantic Layer Summit 2026 Spotlights Business Context as Critical Infrastructure for Enterprise AIMay 21 at 12:44 PM | finance.yahoo.comChevron Introduces Next-gen Techron in U.S. Chevron and Texaco GasolinesMay 21 at 12:44 PM | finance.yahoo.comCan Refining Strength Drive Petrobras' Earnings Growth?May 21 at 12:44 PM | finance.yahoo.comExxonMobil's Resilience: What Sets it Apart in Uncertain TimesMay 21 at 12:44 PM | finance.yahoo.comCredo Technology and Birkenstock have been highlighted as Zacks Bull and Bear of the DayMay 21 at 12:44 PM | finance.yahoo.comCan ConocoPhillips Sustain Long-Term Growth in the Lower 48?May 21 at 12:44 PM | finance.yahoo.comAdvisory: Chevron to Participate in Fireside Q&A at Bernstein 42nd Annual Strategic Decisions ConferenceMay 21 at 9:00 AM | businesswire.comChevron Corporation $CVX Shares Acquired by Global Retirement Partners LLCMay 21 at 7:59 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026The Crude Reality: Pullback Creates High-Conviction Opportunity in ChevronBy Jeffrey Neal Johnson | April 29, 2026Chevron's Pullback May Be a Buying Opportunity—Even If the War EndsBy Sam Quirke | April 26, 2026The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatBy Jessica Mitacek | May 2, 2026AMCR, CVX, and ABBV Company DescriptionsAbbVie NYSE:ABBV$216.02 +1.52 (+0.71%) Closing price 03:59 PM EasternExtended Trading$216.39 +0.37 (+0.17%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Amcor NYSE:AMCR$38.43 -0.07 (-0.19%) Closing price 03:59 PM EasternExtended Trading$38.42 0.00 (0.00%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Amcor plc develops, produces, and sells packaging products in Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company operates through two segments, Flexibles and Rigid Packaging. The Flexibles segment provides flexible and film packaging products in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Rigid Packaging segment offers rigid containers for various beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads, and personal care items; and plastic caps for various applications. The company sells its products through its direct sales force. Amcor plc was incorporated in 2018 and is headquartered in Zurich, Switzerland.Chevron NYSE:CVX$191.51 +0.50 (+0.26%) Closing price 03:59 PM EasternExtended Trading$191.70 +0.19 (+0.10%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
